On May 27, Thermo Fisher Scientific and well-known electron microscope manufacturer FEI jointly announced that the board of directors of both parties had unanimously approved the acquisition of FEI by Thermo Fisher at a price of US$107.50 per share for a total of US$4.2 billion. The latter designs and manufactures a wide range of micron, nanoscale and micron micron electron microscopes for life science exploration. Providing images and information in the micro, nano and picmi fields, headquartered in Hillsboro, Oregon, with more than 3,000 employees worldwide, R&D, sales and manufacturing operations in Europe and the US, with revenues of $930 million in 2015. As part of the transaction, Thermo Fisher Scientific's offer for FEI (NASDAQ:FEIC) was $107.50 per share, a 14% premium to FEI's closing price of $94.58 per share on May 26; however, on May 27, FEI's closing price It surged 14.33% to $108.13 per share. Thermo Fisher expects the end of the first full year after the completion of the transaction will result in an increase of 30 cents per share, with a three-year synergy of $80 million. The transaction is expected to be completed in early 2017 and is still subject to FEI shareholders and relevant regulatory authorities and meets customary closing conditions. Upon completion of the transaction, FEI will become a member of Thermo Scientific's Analytical Instruments division, and FEI's electron microscope platform will support Thermo Fisher's mass spectrometry system for the detection of material composition. Marc N. Casper, President and CEO of Thermo Fisher Scientific, said that the addition of FEI is an excellent strategy for the company, which will create significant value for its customers and shareholders, increasingly in the life sciences sector. Many users use electron microscopy to study the structure of proteins. The technology obtained from FEI will be a good complement to the company's mass spectrometry technology, making Thermo Fisher the best position in this trend. As an outstanding leader in life sciences, Thermo Fisher will leverage the company's global scale and commercialization to enable FEI's products to be promoted across a broad spectrum of biopharmaceutical customers. Two months ago, Thermo Fishers had just acquired Affymetrix, a well-known gene chip company, to try to improve the competitiveness of its portfolio with this small, complementary transaction. Thermo Fisher released to analysts last week that it would use $12 billion in capital for similar acquisitions over the next three years, raising revenue by $3 billion. Moisturizing refers to maintaining the water content of the skin, especially the epidermis of the facial skin, by using skin care products and maintaining the body's water balance. This catagory includes Cosmetic Raw Material with skin moisturizing effects, such as Hyaluronic Acid, Poly Glutamic Acid, pyrrolidone carboxylic acid etc. Skin Moisturizing,Cosmetic Grade Sodium Hyaluronate,High Molecular Hyaluronic Acid,Hyaluronic Acid Powder Hunan Insen Biotech Co., Ltd , https://www.insenhealth.com